# New clinical trials in Guadeloupe: 38 since Nov 2024

Updated October 1, 2026.

38 clinical studies with a site in Guadeloupe were first posted on ClinicalTrials.gov from December 18, 2024 to October 1, 2026; 1 have an industry sponsor and 27 are recruiting or about to. The newest, NCT07852442, was posted on October 1, 2026: Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell... (Centre Hospitalier Universitaire de la Guadeloupe).

## The full list

New clinical trials with a site in Guadeloupe: 38 rows for $5, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/country/guadeloupe

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 38
- Industry sponsored: 1
- Recruiting or not yet: 27
- Latest posted: October 1, 2026

## Newest trials

The newest 38 of 38, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 1, 2026 | NCT07852442 | Comparison of Thrombin Generation, Platelet Activation and Aggregation Profiles in Patients With Sickle Cell Disease Depending on Their SS... | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Not yet recruiting | Sickle Cell Disease, Venous Thromboembolism | 60 | France, Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852442) |
| September 21, 2026 | NCT07830030 | Metabolic Status and Risk of Chronic Kidney Disease in French Overseas Populations With Morbid Obesity (OBECAMcohort). | Clinique | Observational | Active not recruiting | Morbid Obesity, Chronic Kidney Disease (Stage 3-4) | 480 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830030) |
| July 27, 2026 | NCT07729202 | Prevalence of Hepatitis E During Follow-up Liver and Kidney Transplant Patients in Guadeloupe, French West Indies | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Completed | Hepatitis E | 95 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07729202) |
| June 2, 2026 | NCT07620418 | CapExchange: A Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery | EPSM de la Guadeloupe | Not applicable | Not yet recruiting | Mental Disorder, Psychosocial Rehabilitation | 15 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620418) |
| May 28, 2026 | NCT07611994 | Analysis of Chlordecone Tissue Concentrations in Patients Treated for Thyroid Surgery at Guadeloupe University Hospital | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Not yet recruiting | Thyroid and Parathyroid Surgery | 69 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07611994) |
| May 11, 2026 | NCT07579104 | Pyogenic Liver Abcess in Guadeloupe | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Completed | Liver Abscess, Pyogenic | 58 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07579104) |
| May 8, 2026 | NCT07576374 | Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Indies | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Not yet recruiting | Metabolic Diseases, Diabetes Mellitus (Type 2), Genetic Variation, Genetic Profile, Glucose Metabolism Disorders | 118 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576374) |
| May 8, 2026 | NCT07576361 | Impact of Microbiome in Endometriosis Development | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Completed | Endometriosis | 48 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576361) |
| March 4, 2026 | NCT07449520 | Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial) | IHU Strasbourg | Observational | Recruiting | Obesity | 300 | France, Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07449520) |
| January 9, 2026 | NCT07330830 | Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo) | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) | 600 | French Guiana, Guadeloupe, Reunion | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07330830) |
| January 9, 2026 | NCT07330804 | STUDY OF THE DOUBLE POLYMORPHISM (THR 555ILE) AND (GLU568PRO) OF THE CORIN GENE AS A RISK FACTOR FOR ARTERIAL HYPERTENSION IN A POPULATION... | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Recruiting | High Blood Pressure | 370 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07330804) |
| December 18, 2025 | NCT07292454 | Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Not yet recruiting | HELICOBACTER PYLORI INFECTIONS, Inflammatory Bowel Disease (Crohn&#39;s Disease and Ulcerative Colitis) | 100 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07292454) |
| December 17, 2025 | NCT07288723 | Chronic Kidney Disease : Role of Biological Factors and Apolipoprotein L1 Encoding Gene (APOL1) | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Completed | Chronic Kidney Diseases | 88 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07288723) |
| December 11, 2025 | NCT07277023 | The Influence of micro-and Macro Vascular Dysfunction on Clinical Severity in Adults With Sickle Cell Anemia (SS) and Sickle Cell... | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Completed | Sickle Cell Anemia | 49 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277023) |
| December 10, 2025 | NCT07274254 | Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease | Nantes University Hospital | Phase 3 | Recruiting | Vaso-Occlusive Pain Episode in Sickle Cell Disease | 104 | France, Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07274254) |
| December 5, 2025 | NCT07266376 | Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Not yet recruiting | Mental Disorder, Schizophrenia Diagnosis | 116 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266376) |
| December 5, 2025 | NCT07265999 | Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Dermatomyositis | 10 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07265999) |
| December 5, 2025 | NCT07265986 | Comparison Between a Robotic Tele-echo-cardiography Technique and a Standard Echocardiography in the Management of Heart Failure in the... | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Recruiting | Heart Failure, Remote Consultation, Teleconsultation, Echocardiography, Doppler | 50 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07265986) |
| November 26, 2025 | NCT07251049 | Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Acute Encephalitis, Acute Myelitis | 100 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07251049) |
| November 26, 2025 | NCT07251036 | Serum Chordecone Concentration in Guadeloupean Population: Impact of a Multidisciplinary Support Program on the Reduction of the... | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Recruiting | Chlordecone Level | 3,000 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07251036) |
| November 18, 2025 | NCT07233447 | Prevalence of H. Pylori in Stomach Cancers in the West Indies | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Oncology Epidemiology, Risk Factors | 100 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07233447) |
| November 18, 2025 | NCT07233434 | Screening for Type 2 Diabetes by Oral Glucose Tolerance Test in the Population Groups Not Diagnosed by Fasting Blood Glucose in Guadeloupe | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Recruiting | Non-Diabetic | 120 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07233434) |
| November 18, 2025 | NCT07233356 | Novel Risk Factors and Localization of Peripheral Arterial Disease | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Completed | Atherosclerotic Peripheral Arterial Disease, Hemoglobin A1c Protein, Human, Guadeloupe | 123 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07233356) |
| November 17, 2025 | NCT07231510 | Chlordecone Exposure and Female Fertility | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Infertility Female | 634 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07231510) |
| November 17, 2025 | NCT07230925 | Study of the Rate of Progression of Cerebral Ischemia in Afro-Caribbeans | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Not yet recruiting | Ischemic Stroke, Cerebral Ischemia, Endovascular Treatments | 135 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07230925) |
| September 24, 2025 | NCT07190911 | Efficacy of Olfactive Training on Loss of Smell and Taste Caused by SARS CoV2 COVID-19 (Covid-Smell) | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Completed | COVID - 19 | 40 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190911) |
| July 25, 2025 | NCT07086703 | Targeted Temperature Management at 33°C Versus Controlled Normothermia for In-hospital Cardiac Arrest | Nantes University Hospital | Not applicable | Recruiting | Cardiac Arrest | 788 | Belgium, France, Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07086703) |
| June 27, 2025 | NCT07040488 | Study of Infrared Thermography in Diabetic Foot in Guadeloupe | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Diabetic Foot Infection | 150 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07040488) |
| June 12, 2025 | NCT07018180 | Interventional Clinical Trial Evaluating COVER PATCH CAPTEUR PROTECT Support Solutions for Continuous Glucose Monitoring Sensors in... | CAPTEUR PROTECT | Not applicable | Recruiting | Diabetes | 194 | France, Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07018180) |
| June 3, 2025 | NCT07001189 | Impact of Regional Anesthesia on Inflammatory Mechanisms During Vaso-occlusive Crisis in Sickle Cell Patients | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Sickle Cell, Sickle Cell Disease, Vaso-Occlusive Crises | 34 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001189) |
| June 3, 2025 | NCT07000747 | Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | Dengue (Virus); Fever, Sandfly, Sickle Cell Disease | 130 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07000747) |
| May 31, 2025 | NCT06998381 | Ethnic Specificities of S100B Protein Blood Level in Guadeloupe: Cross-sectional Study in Healthy Subjects | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Recruiting | s100b | 200 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06998381) |
| May 23, 2025 | NCT06986837 | Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Completed | Sickle Cell Disease | 92 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06986837) |
| April 24, 2025 | NCT06943209 | SAPLAI : Assessing the faiSAbility of a Peer-to-peer Contraceptive Education Program on Social Networks Aimed at 15- to 19-year-old High... | Centre Hospitalier Universitaire de la Réunion | Observational | Completed | Contraception Behavior | 131 | Guadeloupe, Reunion | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06943209) |
| April 13, 2025 | NCT06926153 | Interventional Study on Smoking Reduction in Psychiatry | GCS-CCOMS | Not applicable | Recruiting | Tobacco Addiction | 6,500 | France, Guadeloupe, Reunion | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06926153) |
| February 27, 2025 | NCT06850337 | Megakaryocyte Heterogeneity in Sickle Cell Disease | Centre Hospitalier Universitaire de la Guadeloupe | Observational | Not yet recruiting | Sickle Cell Disease (SCD) | 100 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06850337) |
| December 20, 2024 | NCT06743529 | Immediate Versus Substantiated Antibiotic Therapy in Suspected Non-Severe Ventilator-Associated Pneumonia | Nantes University Hospital | Not applicable | Recruiting | Ventilator-Associated Pneumonia (VAP) | 686 | France, Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06743529) |
| December 18, 2024 | NCT06738810 | : Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function... | Centre Hospitalier Universitaire de la Guadeloupe | Not applicable | Completed | Non-alcoholic Steato-hepatitis | 103 | Guadeloupe | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06738810) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Centre Hospitalier Universitaire de la Guadeloupe | 29 | October 1, 2026 |
| Nantes University Hospital | 3 | December 10, 2025 |
| Clinique | 1 | September 21, 2026 |
| EPSM de la Guadeloupe | 1 | June 2, 2026 |
| IHU Strasbourg | 1 | March 4, 2026 |
| CAPTEUR PROTECT | 1 | June 12, 2025 |
| Centre Hospitalier Universitaire de la Réunion | 1 | April 24, 2025 |
| GCS-CCOMS | 1 | April 13, 2025 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Anemia, Sickle Cell](https://specstream.ai/data/clinical-trials/condition/anemia-sickle-cell) | 7 | October 1, 2026 |
| [Diabetes Mellitus, Type 2](https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-2) | 3 | May 8, 2026 |
| [Renal Insufficiency, Chronic](https://specstream.ai/data/clinical-trials/condition/renal-insufficiency-chronic) | 2 | September 21, 2026 |
| [Mental Disorders](https://specstream.ai/data/clinical-trials/condition/mental-disorders) | 2 | June 2, 2026 |
| [Endometriosis](https://specstream.ai/data/clinical-trials/condition/endometriosis) | 2 | May 8, 2026 |
| [Inflammation](https://specstream.ai/data/clinical-trials/condition/inflammation) | 2 | May 8, 2026 |
| Vaso-Occlusive Crises | 2 | December 10, 2025 |
| Venous Thromboembolism | 1 | October 1, 2026 |
| Obesity, Morbid | 1 | September 21, 2026 |
| [Metabolic Syndrome](https://specstream.ai/data/clinical-trials/condition/metabolic-syndrome) | 1 | September 21, 2026 |
| Hepatitis E | 1 | July 27, 2026 |
| Thyroid Diseases | 1 | May 28, 2026 |
| Liver Abscess, Pyogenic | 1 | May 11, 2026 |
| Liver Abscess | 1 | May 11, 2026 |
| Metabolic Diseases | 1 | May 8, 2026 |
| Glucose Metabolism Disorders | 1 | May 8, 2026 |
| Ketosis | 1 | May 8, 2026 |
| Dysbiosis | 1 | May 8, 2026 |
| [Obesity](https://specstream.ai/data/clinical-trials/condition/obesity) | 1 | March 4, 2026 |
| [Hypertension](https://specstream.ai/data/clinical-trials/condition/hypertension) | 1 | January 9, 2026 |
| [Inflammatory Bowel Diseases](https://specstream.ai/data/clinical-trials/condition/inflammatory-bowel-diseases) | 1 | December 18, 2025 |
| [Colitis, Ulcerative](https://specstream.ai/data/clinical-trials/condition/colitis-ulcerative) | 1 | December 18, 2025 |
| Hemoglobin C Disease | 1 | December 11, 2025 |
| Acute Chest Syndrome | 1 | December 10, 2025 |
| [Agnosia](https://specstream.ai/data/clinical-trials/condition/agnosia) | 1 | December 10, 2025 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 22 | October 1, 2026 |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 15 | July 27, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 1 | December 10, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).
